VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹16 Cr | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-0.68 Cr |
| Mar2021 | ₹3.63 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 42.73 | |
| Mar2024 | ₹11 Cr | 2.54 | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-0.68 Cr | Negative | |
| Mar2021 | ₹3.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,378.2 Cr | -4.2% | 31.8% | 333.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.2% |
31.8% |
333.6% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses